Adamis Pharmaceuticals Corporation
S-8 


EXHIBIT 4.01


 

Exhibit 4.01 




 



RESTATED CERTIFICATE OF INCORPORATION OF


ADAMIS PHARMACEUTICALS CORPORATION


 


 


Adamis Pharmaceuticals
Corporation, a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows:


 


FIRST: The name
of this corporation is Adamis Pharmaceuticals Corporation.


 


SECOND: The original
name of this corporation was Cellegy Pharmaceuticals, Inc. and the date of filing of its original Certificate of Incorporation
with the Secretary of State of the State of Delaware was April 22, 2004.


 


THIRD: The Certificate
of Incorporation of said corporation shall be restated to read in full as follows:


 


I.


 


The name of this corporation
is Adamis Pharmaceuticals Corporation (the "Company").


 


II.


 


The address of the registered
office of the Company in the State of Delaware is 2711 Centerville Road, Suite 400, Wilmington, DE 19808. The name of the
registered agent at that address is Corporation Service Company.


 


III.


 


The purpose of the Company
is to engage in any lawful act or activity for which a corporation may be organized under the Delaware General Corporation Law
("DGCL").


 


IV.


 


A. The Company is
authorized to issue two classes of stock to be designated, respectively, "Common Stock" and "Preferred Stock."
The total number of shares of all classes of capital stock which the Company shall have authority to issue is one hundred ten million
(110,000,000), of which one hundred million (100,000,000) shares shall be Common Stock, having a par value of $0.0001 per share
(the "Common Stock"), and ten million (10,000,000) shares shall be Preferred Stock, having a par value
of $0.0001 (the "Preferred Stock").


 


B. The Preferred
Stock may be issued from time to time in one or more series. The Board of Directors of the Company (the "Board of Directors"
) is hereby expressly authorized to provide for the issue of any or all of the unissued and undesignated shares of the Preferred
Stock in one or more series, and to fix the number of shares and to determine or alter for each such series, such voting powers,
full or limited, or no voting powers, and such designation, preferences, and relative, participating, optional, or other rights
and such qualifications,



    	1



    	 



    limitations, or restrictions thereof, as shall
be stated and expressed in the resolution or resolutions adopted by the Board of Directors providing for the issuance of such shares
and as may be permitted by the DGCL. The Board of Directors is also expressly authorized to increase or decrease the number of
shares of any series subsequent to the issuance of shares of that series, but not below the number of shares of such series then
outstanding. In case the number of shares of any series shall be decreased in accordance with the foregoing sentence, the shares
constituting such decrease shall resume the status that they had prior to the adoption
of the resolution originally fixing the number of shares of such series. The number of authorized shares of Preferred Stock may
be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders
of a majority of the Common Stock, without a vote of the holders of the Preferred Stock, or of any series thereof, unless a vote
of any such holders is required pursuant to the terms of any certificate of designation filed with respect to any series of Preferred
Stock.


 


 


 


C. Each outstanding
share of Common Stock shall entitle the holder thereof to one vote on each matter properly submitted to the stockholders of the
Company for their vote; provided, however , that, except as otherwise required by law, holders of Common Stock shall not
be entitled to vote on any amendment to this Restated Certificate of Incorporation (including any certificate of designation filed
with respect to any series of Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred
Stock if the holders of such affected series of Preferred Stock are entitled, either separately or together as a class with the
holders of one or more other series of Preferred Stock, to vote thereon by law or pursuant to this Restated Certificate of Incorporation
(including any certificate of designation filed with respect to any series of Preferred Stock).


 


V.


 


For the management of the
business and for the conduct of the affairs of the Company, and in further definition, limitation and regulation of the powers
of the Company, of its directors and of its stockholders or any class thereof, as the case may be, it is further provided that:


 


A. The management
of the business and the conduct of the affairs of the Company shall be vested in its Board of Directors. The number of directors
that shall constitute the Board of Directors shall be fixed exclusively by resolutions adopted by a majority of the authorized
number of directors constituting the Board of Directors.


 


B. No decrease in
the number of directors constituting the Board of Directors shall shorten the term of any incumbent director.


 


C.
Subject to the rights of the holders of any series of Preferred Stock that may be designated from time to time, any vacancies on
the Board of Directors resulting from death, resignation, disqualification, removal or other causes and any newly created directorships
resulting from any increase in the number of directors, shall, unless the Board of Directors determines by resolution that any
such vacancies or newly created directorships shall be filled by the stockholders, except as otherwise provided by law, be filled
only by the affirmative vote of a majority of the directors then in office, even though less than a quorum of the Board of Directors,
and not by the stockholders. Any director elected in accordance with the preceding



    	2



    	 



    sentence shall hold office for the remainder
of the full term of the director for which the vacancy was created or occurred and until such director's successor shall have been
elected and qualified.


 


D. Subject to the
rights of the holders of any series of Preferred Stock that may be designated from time to time, the Board of Directors is expressly
empowered to adopt, amend or repeal the Bylaws of the Company. Any adoption, amendment or repeal of the Bylaws of the Company by
the Board of Directors shall require the approval of a majority of the authorized number of directors. The stockholders shall also
have power to adopt, amend or repeal the Bylaws of the Company, subject to any restrictions which may be set forth in this Restated
Certificate of Incorporation (including any certificate of designation that may be filed from time to time.


 


E. The directors
of the Company need not be elected by written ballot unless the Bylaws of the Company so provide.


 


F. No action shall
be taken by the stockholders of the Company except at an annual or special meeting of stockholders called in accordance with the
Bylaws of the Company. No action shall be taken by the stockholders of the Company by written consent or electronic transmission.


 


 


 


G. Advance notice
of stockholder nominations for the election of directors and of business to be brought by stockholders before any meeting of the
stockholders of the Company shall be given in the manner provided in the Bylaws of the Company.


 


VI.


 


A. The liability
of a director of the Company for monetary damages shall be eliminated to the fullest extent under applicable law. If the DGCL is
amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of
a director of the Company shall be eliminated to the fullest extent permitted by the DGCL, as so amended.


 


B. Any repeal or
modification of this Article shall be prospective and shall not affect the rights under this Article in effect at the time of the
alleged occurrence of any act or omission to act giving rise to liability or indemnification.


 


VII.


 


A. The Company reserves
the right to amend, alter, change or repeal any provision contained in this Restated Certificate of Incorporation, in the manner
now or hereafter prescribed by statute, except as provided in Section B of
this Article, and all rights conferred upon the stockholders herein are granted subject to this reservation.


 


*  *  *  *


 


FOURTH:     This
Restated Certificate of Incorporation has been duly adopted and approved by the Board of Directors in accordance with Section 245
of the DGCL.


 


 



    	3



    	 



     


IN WITNESS WHEREOF,
Adamis Pharmaceuticals Corporation has caused this Restated Certificate of Incorporation to be signed by its Chief Executive Officer,
this 14th day of March, 2014.


 








	 	 	ADAMIS PHARMACEUTICALS CORPORATION
	 	 
	 		/s/ Dennis J. Carlo, Ph.D
	 	 	Dennis J. Carlo, Ph.D
Chief Executive Officer